Does anyone on this forum even understand what exosomes are? You do realise that no two exosomes are alike? How do you expect the FDA to ever approve such a heterogenous product. And how do you expect EX1 to determine the MOA? Its no good just isolating exosomes and seeing if they heal wounds. The real value is when EX1 can engineer exosomes, which is at least 10-15 years away to develop a product that can even be tested.
FYI you lot are just paying for scientific research.
- Forums
- ASX - By Stock
- TYP
- Codiak ($800mil market capitalisation)
TYP
tryptamine therapeutics limited
Add to My Watchlist
0.00%
!
3.2¢

Codiak ($800mil market capitalisation), page-158
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.44M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.2¢ | $39.58K | 1.234M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 966515 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 67037 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 966515 | 0.031 |
6 | 754722 | 0.030 |
5 | 284603 | 0.029 |
5 | 489999 | 0.028 |
3 | 255659 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 67037 | 4 |
0.034 | 471063 | 5 |
0.035 | 252991 | 4 |
0.036 | 332508 | 3 |
0.037 | 495191 | 4 |
Last trade - 12.40pm 22/07/2025 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |